-
-
-
-
-
-
-
Oncolytics Biotech starts phase 2 colorectal cancer study
-
-
-
-
-
-
-
Oncolytics Biotech postpones shareholder meeting due to government shutdown
-
-
-
-
-
-
-
Oncolytics Biotech reports safety data for pelareorep in cancer patients
-
-
-
-
-
-
-
Oncolytics Biotech (ONCY) Tops Q1 EPS by 3c
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Oncolytics Biotech (ONCY)
-
-
-
-
-
-
414,378 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

